A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
Year: 2009
Type: article
Study design: Clinical Trial
Source: Blood
Institution: Charité – Universitätsmedizin Berlin
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1992343552
